Summerset Group Holdings Past Earnings Performance
Past criteria checks 4/6
Summerset Group Holdings has been growing earnings at an average annual rate of 15.7%, while the Healthcare industry saw earnings growing at 13.7% annually. Revenues have been growing at an average rate of 14.2% per year. Summerset Group Holdings's return on equity is 16.7%, and it has net margins of 161.3%.
Key information
15.7%
Earnings growth rate
14.8%
EPS growth rate
| Healthcare Industry Growth | 13.0% |
| Revenue growth rate | 14.2% |
| Return on equity | 16.7% |
| Net Margin | 161.3% |
| Next Earnings Update | 24 Aug 2024 |
Recent past performance updates
Recent updates
At NZ$10.32, Is It Time To Put Summerset Group Holdings Limited (NZSE:SUM) On Your Watch List?
Oct 06
At NZ$10.19, Is It Time To Put Summerset Group Holdings Limited (NZSE:SUM) On Your Watch List?
Jun 08Should You Investigate Summerset Group Holdings Limited (NZSE:SUM) At NZ$13.46?
Jan 12Is There Now An Opportunity In Summerset Group Holdings Limited (NZSE:SUM)?
Jun 13James Ogden Is The Non-Executive Independent Director of Summerset Group Holdings Limited (NZSE:SUM) And They Just Sold 84% Of Their Shares
Mar 20Read This Before Buying Summerset Group Holdings Limited (NZSE:SUM) Shares
Feb 16
Is Summerset Group Holdings Limited (NZSE:SUM) Potentially Undervalued?
Feb 01Is Summerset Group Holdings Limited (NZSE:SUM) Trading At A 42% Discount?
Jan 18Summerset Group Holdings (NZSE:SUM) Has Gifted Shareholders With A Fantastic 253% Total Return On Their Investment
Jan 06Summerset Group Holdings Limited's (NZSE:SUM) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?
Dec 22We Wouldn't Rely On Summerset Group Holdings's (NZSE:SUM) Statutory Earnings As A Guide
Dec 09Here's Why Summerset Group Holdings (NZSE:SUM) Can Manage Its Debt Responsibly
Nov 27Revenue & Expenses BreakdownBeta
How Summerset Group Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 271 | 436 | 0 | 0 |
| 30 Sep 23 | 261 | 352 | 0 | 0 |
| 30 Jun 23 | 252 | 267 | 0 | 0 |
| 31 Mar 23 | 245 | 268 | 0 | 0 |
| 31 Dec 22 | 238 | 269 | 0 | 0 |
| 30 Sep 22 | 231 | 342 | 0 | 0 |
| 30 Jun 22 | 225 | 415 | 0 | 0 |
| 31 Mar 22 | 215 | 479 | 0 | 0 |
| 31 Dec 21 | 205 | 544 | 0 | 0 |
| 30 Sep 21 | 195 | 519 | 0 | 0 |
| 30 Jun 21 | 185 | 494 | 0 | 0 |
| 31 Mar 21 | 179 | 362 | 0 | 0 |
| 31 Dec 20 | 172 | 231 | 0 | 0 |
| 30 Sep 20 | 167 | 157 | 0 | 0 |
| 30 Jun 20 | 162 | 84 | 0 | 0 |
| 31 Mar 20 | 158 | 129 | 0 | 0 |
| 31 Dec 19 | 154 | 175 | 0 | 0 |
| 30 Sep 19 | 149 | 193 | 1 | 0 |
| 30 Jun 19 | 145 | 211 | 1 | 0 |
| 31 Mar 19 | 141 | 213 | 1 | 0 |
| 31 Dec 18 | 137 | 215 | 1 | 0 |
| 30 Sep 18 | 131 | 230 | 1 | 0 |
| 30 Jun 18 | 125 | 246 | 1 | 0 |
| 31 Mar 18 | 118 | 243 | 1 | 0 |
| 31 Dec 17 | 110 | 240 | 1 | 0 |
| 30 Sep 17 | 103 | 213 | 1 | 0 |
| 30 Jun 17 | 97 | 185 | 1 | 0 |
| 31 Mar 17 | 91 | 165 | 1 | 0 |
| 31 Dec 16 | 86 | 145 | 1 | 0 |
| 30 Sep 16 | 81 | 122 | 1 | 0 |
| 30 Jun 16 | 76 | 99 | 0 | 0 |
| 31 Mar 16 | 72 | 92 | 0 | 0 |
| 31 Dec 15 | 68 | 84 | 0 | 0 |
| 30 Sep 15 | 65 | 79 | 0 | 0 |
| 30 Jun 15 | 61 | 75 | 0 | 0 |
| 31 Mar 15 | 58 | 64 | 0 | 0 |
| 31 Dec 14 | 54 | 54 | 0 | 0 |
| 30 Sep 14 | 52 | 46 | 0 | 0 |
| 30 Jun 14 | 49 | 39 | 0 | 0 |
| 31 Mar 14 | 47 | 36 | 0 | 0 |
| 31 Dec 13 | 45 | 34 | 0 | 0 |
| 30 Sep 13 | 43 | 28 | 0 | 0 |
| 30 Jun 13 | 41 | 22 | 0 | 0 |
Quality Earnings: SUM has a large one-off gain of NZ$441.6M impacting its last 12 months of financial results to 31st December, 2023.
Growing Profit Margin: SUM's current net profit margins are higher than last year .
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: SUM's earnings have grown by 15.7% per year over the past 5 years.
Accelerating Growth: SUM's earnings growth over the past year (62.2%) exceeds its 5-year average (15.7% per year).
Earnings vs Industry: SUM earnings growth over the past year (62.2%) exceeded the Healthcare industry -20.1%.
Return on Equity
High ROE: SUM's Return on Equity (16.7%) is considered low.